Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by cytochromeon Jan 12, 2017 11:01am

89 Views

Post# 25699181

RE:RE:RE:RE:Lung cancer would trigger brain PDC sales in 40% of cases

Of course there are many treatments for metastasis...some pretty effective depending on what CA it is. When you reference press releases, you make my point very obvious wrt to hype and conjecture. Stop pumping that TLT PDCs are the answer to every frickin CA known to mankind.....you just make yourself look foolish

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism